At a Glance
Regime: Market At All Time Highs· Open: Gap up · Risk on new positions: Improving · Custom T2108: 21, rising
Secondary Setups: RSKD · AMD · BAND
Tonight After Hours: NEOG, PENG, WS · Tomorrow Before Open: —
Holding: OKTA, DELL, MRNA, ALAB, NET, PBR
Situational Awareness
Market Condition: All Time Highs, Setups Proliferating
Commentary: There are some catalysts today. Notably CEG deal with GOOG and APOG with strong earnings but neither really blows my mind. Market is looking constructive. We have a lot of setups coming into earnings season. I feel like there will be better ways to put our money to work in the coming weeks.

Breadth indicators hooking up nicely as the Indices make new all time highs. Leadership still narrow but improving.
Today In Focus
Existing Positions
Also in Play
Power Plays: RSKD, AMD, BAND



Trade Updates
Open:
OKTA - Earnings Catalyst - 27th August 2026 - 10% Remaining
DELL - Earnings Catalyst - 2nd September 2026 - 70% Remaining
MRNA - Power Play - 17th September 2026 - 40% Remaining
ALAB - Power Play - 5th October 2026 - 100% Remaining
NET - Power Play - 5th October 2026 - 100% Remaining
PBR - PR Catalyst - 5th October 2026 - 100% Remaining
Trims: None
Closed since yesterday:
PBR - PR Catalyst - 5th October 2026 - Stopped Out
PCVX - Biotech Catalyst - 5th October 2026 - Stopped Out
Macro Events (Eastern Time)
Tuesday October 6 2026
8:30 AM - Imports (Aug) (Previous: 399.3 B, Consensus: 416.8 B)
8:30 AM - Exports (Aug) (Previous: 310.7 B, Consensus: 314.6 B)
8:30 AM - Balance of Trade (Aug) (Previous: -88.6 B, Consensus: -102 B)
4:30 PM - API Crude Oil Stock Change (Oct/02) (Previous: 1.02, Consensus: —)
Fed speakers: Williams 9:05 AM, Bowman 10:45 AM, Schmid 1:15 PM, Logan 7:00 PM
IPOs Today
Tue 6 Oct: LUMN - Lumen Technologies, Inc. - NASDAQ - Lumen Technologies, Inc. (MOVING TO NASDAQ FROM NYSE***)
Biotech Calendar
XBI -0.3% on the week and -5.0% on the month, under its 50-day. The sector tailwind is gone for now. Reactions have to prove themselves.
Flagged Charts: N/A
Note: Never front-run biotech catalysts. Wait for the catalyst to hit, then assess if the reaction is tradable. Dates are estimates and can shift.
Full H2 Biotech Watchlist: TradingView
Have a Great Week!
Sean Sharpe


